If You Invested $100 in CRISPR Therapeutics’ IPO, This Is How Much Money You’d Have Now – Motley Fool

There are good investments and there are great investments. CRISPR Therapeutics (NASDAQ:CRSP) stock certainly qualifies as the latter.

This is a company that, four years after it went public, has only been profitable for one year, yet its future is so promising that its stock is trading for 540% more than it did in 2016.

What's the big deal about CRISPR Therapeutics? The biopharmaceutical company says it is using breakthrough gene-altering therapies to treat diseases such as sickle cell disease (SCD) and beta-thalassemia, both of which are inherited blood disorders that don't have a cure and require frequent blood transfusions. The company is also working on gene therapies to treat type 1 diabetes, muscular dystrophy, cystic fibrosis, multiple myeloma, and solid tumors in pancreatic cancer and lung cancer.

Image source: Getty Images.

CRISPR Therapeutics is actually named for the technology it uses: CRISPR stands for "clusters of regularly interspaced short palindromic repeats." The gene-editing technology uses Cas9 proteins to locate a sequenceof DNA within a cell and alter it.

Though CRISPR Therapeutics has yet to bring a product to market, some of its clinical trials have had amazing results. In June, the Swiss company announced that in a joint trial with Vertex Pharmaceuticals (NASDAQ:VRTX), five patients with beta-thalassemia and two patients with sickle cell disease were treated with gene therapy CTX001.

Two of the early beta-thalassemia patients are now transfusion independent 15 months afterward. The first SCD patient in the trial is transfusion independent and free of vaso-occlusive crises (VOCs), a painful condition when blood vessels are blocked by sickled red blood cells, seven months after his dose of CTX001.

Beta-thalassemia, which reduces the body's production of hemoglobin, is extremely rare. Sickle cell anemia is common among African Americans but also can affect Latinos and people of Indian, Asian, Mediterranean backgrounds. The U.S. Department of Health and Human Services says 300,000 babies worldwide are born every year with the disease and 100,000 people in the United States are currently living with the disease.

While the results are quite promising, the study is still in its infancy. .

If you had invested $100 in CRISPR Therapeutics stock when it went public in 2016, how much would that be worth today?

By the end of the day on Oct. 19, 2016, the day CRISPR Therapeutics went public, the stock was trading at $14.09, you would have bought seven shares. Assuming you bought at that price, your original $98.63 investment would be worth $632.45 as of the close of trading Friday when the stock went for $90.35 per share. That's a gain of 541%.

CRISPR Therapeutics isn't the only biotech to use CRISPR-Cas9 technology. Others include Editas Medicine (NASDAQ:EDIT) and Intellia Therapeutics (NASDAQ:NTLA), both of which went public in 2016. Neither of those has done quite as well as CRISPR Therapeutics since its IPO.

Compared to a biotech ETF such as the iShares NASDAQ Biotechnology ETF (NASDAQ:IBB), CRISPR has shined. The ETF closed at $89.16 on the day of CRISPR's IPO. As of Friday's close, IBB was at $136.41. If you had invested $100 on Oct. 19, 2016, you would have a return of only 36%.

CRSP data by YCharts

Clinical-stage biotech stocks are inherently risky plays because there are so many hurdles these companies have to clear before they can make money. The therapies have to be approved by the Food and Drug Administration (FDA) and many therapies look promising only to fail in late-stage clinical trials.

CRISPR Therapeutics looks like a solid bet, though, both from a cash standpoint and in its strength of pipeline. The company has four candidates already in trials.It is already making money, though not a lot of it. Last year, CRISPR Therapeutics generated net income of $66.8 million, thanks to $289.5 million in collaboration revenue.

The other major question for clinical-stage biotechs is whether they have enough capital to pay for research and development until the therapies pay off. Last quarter, the company burned through $54 million in cash. However, CRISPR Therapeutics says it has more than $900 million left, so it can continue that burn rate for more than four years. The possibility that CRISPR Therapeutics' technology could actually cure diseases, not just treat them, easily makes this a risk worth taking.

Continued here:

If You Invested $100 in CRISPR Therapeutics' IPO, This Is How Much Money You'd Have Now - Motley Fool

Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing…

SAN DIEGO and BOSTON, July 24, 2020 /PRNewswire/ --Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") and SmartPharm Therapeutics, Inc. ("SmartPharm") announced today the signing of a letter of intent for Sorrento to acquire SmartPharm, a gene-encoded therapeutics company developing non-viral DNA and RNA gene delivery platforms for COVID-19 and rare diseases, with broad potential for application in enhancing antibody-centric therapeutics, including against COVID-19. The transaction is expected to close in August 2020. Financial terms of the deal were not disclosed.

Sorrento and SmartPharm previously announced a research and development collaboration to encode and express in vivo Sorrento's proprietary SARS-CoV-2 neutralizing monoclonal antibodies utilizing SmartPharm's Gene Mab plasmid nanoparticle platform.

Sorrento plans to accelerate the development of multiple candidates for in vivo gene-encoded expression of Sorrento's antibodies, starting with Sorrento's previously announced STI-1499, or COVI-GUARD, which is currently moving through preclinical and manufacturing requirements with an IND submission targeted for August 2020. The initial clinical trial for STI-1499 is expected to be in ICU patients to ensure safety and potentially allow a preliminary look at efficacy. In vitro results so far have demonstrated STI-1499's ability to completely neutralize SARS-CoV-2 infection at low doses, making STI-1499 Sorrento's lead candidate for potential cost-effective passive protection against COVID-19.

SmartPharm's Gene Mab platform delivers to muscles a novel low-immunogenic DNA plasmid encoded with a therapeutic antibody for long-lasting expression in vivo. If clinical trials are successful, a single administration of STI-1499dpi (DNA plasmid injection) could allow the recipient's own muscle cells to produce the antibody for a prolonged period of time after a single injection, potentially providing extended protection against COVID-19 for periods of time that might provide an alternative to vaccines. Manufacturing of DNA plasmids (in bacterial fermenters) can be done with Sorrento's in-house cGMP capabilities for a fraction of the cost associated with traditional antibody manufacturing.

"We are very encouraged by the preclinical data generated thus far by our STI-1499 neutralizing antibody against COVID-19," said Henry Ji, Ph.D., CEO of Sorrento Therapeutics. "We are excited about the prospect of leveraging SmartPharm's Gene Mab platform in combination with our G-MAB library to produce next-generation gene-encoded antibody candidates against a host of pathogens and cancer cell types. Being able to stimulate the body to produce in vivo our most potent antibodies at optimized manufacturing costs will offer an additional competitive advantage as Sorrento transitions from product development to full scale manufacturing and commercialization."

About SmartPharm Therapeutics

SmartPharm Therapeutics, Inc. is a privately held, development stage biopharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of serious or rare diseases with the vision of creating "Biologics from Within." SmartPharm is currently developing a novel pipeline of non-viral, gene-encoded proteins for the treatment of conditions that require biologic therapy such enzyme replacement and tissue restoration. SmartPharm commenced operations in 2018 and is headquartered in Cambridge, MA, USA. For more information, please visit http://www.smartpharmtx.com.

About Sorrento Therapeutics, Inc.

Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies ("G-MAB library"), clinical stage immuno-cellular therapies ("CAR-T", "DAR-T"), antibody-drug conjugates ("ADCs"), and clinical stage oncolytic virus ("Seprehvir", "Seprehvec"). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including COVIDTRAP, ACE-MAB, COVI-MAB, COVI-GUARD, COVI-SHIELD and T-VIVA-19.

Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a first-in-class (TRPV1 agonist) non-opioid pain management small molecule, resiniferatoxin ("RTX"), and ZTlido (lidocaine topical system) 1.8% for the treatment of post-herpetic neuralgia. RTX is completing a phase IB trial for intractable pain associated with cancer and a phase 1B trial in osteoarthritis patients. ZTlido was approved by the FDA on February 28, 2018.

For more information visit http://www.sorrentotherapeutics.com

Forward-Looking Statements

This press release and any statements made for and during any presentation or meeting contain forward-looking statements related toSorrento Therapeutics, Inc., under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995 and subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include statements regarding the proposed acquisition of SmartPharm; the potential effects that the acquisition of SmartPharm may have on Sorrento's business and product candidate pipeline; the expected timing for the closing of the transaction; the initiation and completion of ongoing studies for COVID-19 using antibodies and gene-encoded antibodies, and data read-outs related thereto; the potency and potential blocking capabilities of STI-1499 and STI-1499dpi and their respective impact on SARS-CoV-2; the expected length of any antiviral protection provided by STI-1499 and STI-1499dpi; the potential administration and applications of STI-1499 and STI-1499dpi, alone or in combination; the timeline and status of preclinical testing for STI-1499 and STI-1499dpi; the expected timing of an IND submission for STI-1499; expectations regarding the initial clinical trial for STI-1499; the potential safety and efficacy of STI-1499 and STI-1499dpi; the therapeutic potential of STI-1499 and STI-1499dpi for SARS-CoV-2 and COVID-19; the potential costs associated with manufacturing STI-1499dpi and other DNA plasmids; Sorrento's ability to produce antibody candidates against pathogens and cancer cells; Sorrento's ability to transition from product development to full scale manufacturing and commercialization; and Sorrento's potential position in the anti-viral immunity industry. Risks and uncertainties that could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements, include, but are not limited to: risks related to Sorrento's technologies and prospects with newly acquired technologies, including the proposed acquisition of SmartPharm and the utilization of SmartPharm's Gene-Encoded Therapeutics (GET) platforms for the treatment and prevention of coronavirus infections and other pathogens and cancer cells; risks related to seeking regulatory approvals and conducting clinical trials; the clinical and commercial success of the treatment and prevention of coronavirus infections using monoclonal antibodies and gene-encoded antibodies; the viability and success of using monoclonal antibodies and gene-encoded antibodies for treatments in anti-viral therapeutic areas, including coronavirus; clinical development risks, including risks in the progress, timing, cost and results of clinical trials and product development programs; risk of difficulties or delays in obtaining regulatory approvals; risks that prior study and trial results may not be replicated in future studies and trials; risks that clinical study results may not meet any or all endpoints of a clinical study and that any data generated from such studies may not support a regulatory submission or approval; risks related to seeking regulatory approvals and conducting clinical trials; risks of manufacturing drug product; risks related to leveraging the expertise of its employees, subsidiaries, affiliates and partners to assist the company in the execution of its strategies; risks related to the global impact of COVID-19 and other risks that are described in Sorrento's most recent periodic reports filed with theSecurities and Exchange Commission, including Sorrento's Annual Report on Form 10-K for the year endedDecember 31, 2019, and subsequent Quarterly Reports on Form 10-Q filed with theSecurities and Exchange Commission, including the risk factors set forth in those filings. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release and we undertake no obligation to update any forward-looking statement in this press release except as required by law.

Media and Investor Relations

Contact: Dani FrankEmail: [emailprotected]

Sorrento and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.G-MAB, COVI-GUARD, COVI-SHIELD, COVIDTRAP, T-VIVA-19, COVI-MAB, ACE-MAB, COVI-TRACK, Saving-Life and Improving-Life are trademarks of Sorrento Therapeutics, Inc.

ZTlido is a trademark owned by Scilex Pharmaceuticals Inc.All other trademarks are the property of their respective owners. 2020 Sorrento Therapeutics, Inc. All Rights Reserved.

SOURCE Sorrento Therapeutics, Inc.

Home

Continue reading here:

Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing...

Gene Therapy Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth|Bluebird Bio, Sangamo, Spark…

QY Research has Published Latest Trending Report on Global Gene Therapy Market

Los Angeles, United State, The report titledGlobal Gene Therapy Marketis one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Gene Therapy market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Gene Therapy market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Gene Therapy market is carefully analyzed and researched about by the market analysts.

Request Sample Report and Full Report TOC:https://www.qyresearch.com/sample-form/form/1436547/global-gene-therapy-market

The Essential Content Covered in the GlobalGene Therapy Market Report:

* Top Key Company Profiles.* Main Business and Rival Information* SWOT Analysis and PESTEL Analysis* Production, Sales, Revenue, Price and Gross Margin* Market Share and Size

Global Gene Therapy Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026. According to the latest report added to the online repository of QY Research the Gene Therapy market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Top Players of Gene Therapy Market are Studied: Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene

The report provides a 6-year forecast (2020-2026) assessed based on how the Gene Therapy market is predicted to grow in major regions likeUSA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.

Segmentation by Type:Ex vivoIn Vivo

Segmentation by Application:CancerMonogenicInfectious diseaseCardiovascular diseaseOther

Reasons to Buy this Report:

Table of Contents

Table of Contents1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Gene Therapy Revenue

1.4 Market Analysis by Type

1.4.1 Global Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026

1.4.2 Ex vivo

1.4.3 In Vivo

1.5 Market by Application

1.5.1 Global Gene Therapy Market Share by Application: 2020 VS 2026

1.5.2 Cancer

1.5.3 Monogenic

1.5.4 Infectious disease

1.5.5 Cardiovascular disease

1.5.6 Other 1.6 Study Objectives 1.7 Years Considered2 Global Growth Trends by Regions

2.1 Gene Therapy Market Perspective (2015-2026)

2.2 Gene Therapy Growth Trends by Regions

2.2.1 Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 Gene Therapy Historic Market Share by Regions (2015-2020)

2.2.3 Gene Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porters Five Forces Analysis

2.3.5 Gene Therapy Market Growth Strategy

2.3.6 Primary Interviews with Key Gene Therapy Players (Opinion Leaders)3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy Players by Market Size

3.1.1 Global Top Gene Therapy Players by Revenue (2015-2020)

3.1.2 Global Gene Therapy Revenue Market Share by Players (2015-2020)

3.1.3 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global Gene Therapy Market Concentration Ratio

3.2.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2019

3.3 Gene Therapy Key Players Head office and Area Served

3.4 Key Players Gene Therapy Product Solution and Service

3.5 Date of Enter into Gene Therapy Market

3.6 Mergers & Acquisitions, Expansion Plans4 Breakdown Data by Type (2015-2026)

4.1 Global Gene Therapy Historic Market Size by Type (2015-2020)

4.2 Global Gene Therapy Forecasted Market Size by Type (2021-2026)5 Gene Therapy Breakdown Data by Application (2015-2026)

5.1 Global Gene Therapy Market Size by Application (2015-2020)

5.2 Global Gene Therapy Forecasted Market Size by Application (2021-2026)6 North America

6.1 North America Gene Therapy Market Size (2015-2020)

6.2 Gene Therapy Key Players in North America (2019-2020)

6.3 North America Gene Therapy Market Size by Type (2015-2020)

6.4 North America Gene Therapy Market Size by Application (2015-2020)7 Europe

7.1 Europe Gene Therapy Market Size (2015-2020)

7.2 Gene Therapy Key Players in Europe (2019-2020)

7.3 Europe Gene Therapy Market Size by Type (2015-2020)

7.4 Europe Gene Therapy Market Size by Application (2015-2020)8 China

8.1 China Gene Therapy Market Size (2015-2020)

8.2 Gene Therapy Key Players in China (2019-2020)

8.3 China Gene Therapy Market Size by Type (2015-2020)

8.4 China Gene Therapy Market Size by Application (2015-2020)9 Japan

9.1 Japan Gene Therapy Market Size (2015-2020)

9.2 Gene Therapy Key Players in Japan (2019-2020)

9.3 Japan Gene Therapy Market Size by Type (2015-2020)

9.4 Japan Gene Therapy Market Size by Application (2015-2020)10 Southeast Asia

10.1 Southeast Asia Gene Therapy Market Size (2015-2020)

10.2 Gene Therapy Key Players in Southeast Asia (2019-2020)

10.3 Southeast Asia Gene Therapy Market Size by Type (2015-2020)

10.4 Southeast Asia Gene Therapy Market Size by Application (2015-2020)11 India

11.1 India Gene Therapy Market Size (2015-2020)

11.2 Gene Therapy Key Players in India (2019-2020)

11.3 India Gene Therapy Market Size by Type (2015-2020)

11.4 India Gene Therapy Market Size by Application (2015-2020)12 Central & South America

12.1 Central & South America Gene Therapy Market Size (2015-2020)

12.2 Gene Therapy Key Players in Central & South America (2019-2020)

12.3 Central & South America Gene Therapy Market Size by Type (2015-2020)

12.4 Central & South America Gene Therapy Market Size by Application (2015-2020)13Key Players Profiles

13.1 Bluebird Bio

13.1.1 Bluebird Bio Company Details

13.1.2 Bluebird Bio Business Overview and Its Total Revenue

13.1.3 Bluebird Bio Gene Therapy Introduction

13.1.4 Bluebird Bio Revenue in Gene Therapy Business (2015-2020))

13.1.5 Bluebird Bio Recent Development

13.2 Sangamo

13.2.1 Sangamo Company Details

13.2.2 Sangamo Business Overview and Its Total Revenue

13.2.3 Sangamo Gene Therapy Introduction

13.2.4 Sangamo Revenue in Gene Therapy Business (2015-2020)

13.2.5 Sangamo Recent Development

13.3 Spark Therapeutics

13.3.1 Spark Therapeutics Company Details

13.3.2 Spark Therapeutics Business Overview and Its Total Revenue

13.3.3 Spark Therapeutics Gene Therapy Introduction

13.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2015-2020)

13.3.5 Spark Therapeutics Recent Development

13.4 Dimension Therapeutics

13.4.1 Dimension Therapeutics Company Details

Original post:

Gene Therapy Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth|Bluebird Bio, Sangamo, Spark...

After another tough quarter, healthcare companies pin hopes on brighter H2’20 – S&P Global

This article is an overview of the financial results of Johnson & Johnson, Novartis, Roche, Biogen and selected other healthcare companies who have reported their earnings since July 16.

Many of the top healthcare companies reporting second-quarter earnings over the past week have seen COVID-19 continue to impact revenues. But some are cautiously optimistic for the second half of the year, as they learn to better navigate the pandemic.

The biggest drug- and device-maker by market cap, Johnson & Johnson reported a 35.3% decline in its year-over-year earnings, driven in part by a 33.9% fall in medical device sales. CFO Joseph Wolk said on a July 16 earnings call that the company had previously expected to wait until the fourth quarter for a rebound in these sales, but the turnaround began earlier than expected resulting in the company raising its full-year guidance. While CEO Alex Gorsky expressed concern about a second wave of COVID-19, he pointed out that better-prepared hospitals mean the global impact is unlikely to reach levels seen in the spring.

Novartis CEO Vas NarasimhanSource: Novartis

Swiss pharmaceutical company Novartis AG reported relatively unchanged earnings year over year for the quarter, with the pandemic's effect felt most keenly on its ophthalmology and dermatology businesses, as well as therapies requiring hospital stays. This was partially offset by sales of heart disease drug Entresto, gene therapy Zolgensma and blockbuster psoriasis medicine Cosentyx.

The Basel, Switzerland-based company will not join the race to find a coronavirus vaccine, CEO Vas Narasimhan said on a July 21 earnings call. Instead, the company is focused on pivotal studies in more than 20 medicines, as well as researching inhibitors against both the current and future coronaviruses. In addition, Narasimhan expects strong uptake in Europe for nuclear therapy Lutathera and the drug's expansion in the U.S.

Roche Holding AG, another Swiss pharmaceutical giant and one of the world's biggest cancer drug manufacturers, reported a 6% decline in first-half earnings compared to the same period in 2019, with the pandemic and generic competition of its former blockbuster cancer therapies Herceptin, Avastin and MabThera/Rituxan having a combined impact on sales. However, the company expects the outlook to improve later in the year, with Roche's diagnostics unit's CEO Thomas Schinecker noting that an influx of orders for its coronavirus diagnostic tests from governments worldwide means that even after quadrupling production capacity, the company is still struggling to keep up with demand.

Cambridge, Mass.-based Biogen Inc. reported a 12% increase in second-quarter earnings, with rare disease therapy Spinraza remaining a key seller. The company announced plans to conduct a two-year phase 4 clinical study of the drug combined with Novartis' competitor therapy Zolgensma to treat infants and children with spinal muscular atrophy. GlobalData analysts said Biogen could maintain dominance in the market by demonstrating that Spinraza benefits patients who also receive the Novartis gene therapy.

Impact of reduced elective care

The reduction in elective surgeries, a key strategy to limit the initial spread of the coronavirus, took a heavier toll on healthcare equipment suppliers notably Intuitive Surgical Inc., which reported a $1.01 billion drop in revenue compared to 2019's second quarter. The surgical-robot maker's CFO, Marshall Mohr, said in a July 21 earnings call that "the recovery tail of surgery will be a long one, likely to last many quarters."

Similarly, Abbott Laboratories saw its second-quarter EPS drop 30.5% year over year, but its diabetes line remained resilient. President and CEO Robert Ford said he was "very bullish" about the opportunity for the Libre 2 blood sugar monitoring system approved in the U.S. in June and the Abbott Park, Ill.-based healthcare equipment company reissued its 2020 guidance of mid-single-digits growth.

The pause in elective procedures to slow the pandemic has impacted surgical equipment suppliers.Source: Pixel

HCA Healthcare Inc. blamed a continued drop in admissions and surgery volumes for a 12% decline in its revenue for the second quarter, but the healthcare services provider was already able to point to a rebound in May and June. The company brought in about $1.1 billion in second-quarter income although more than half came from economic relief funds.

CEO Samuel Hazen was hesitant to project into the second half of the year but said the company has gained "muscle memory" to deal with current and future COVID-19 outbreaks. RBC Capital Markets analysts expect HCA to weather the "significant challenges" of the pandemic, noting that "underlying demand in its markets remains strong, despite the likelihood for continued ebb and flow in patient census as reopenings progress and adjust to flare-ups."

Read the original here:

After another tough quarter, healthcare companies pin hopes on brighter H2'20 - S&P Global

Trance – Wikipedia

Trance is an abnormal state of wakefulness in which a person is not self-aware and is either altogether unresponsive to external stimuli (but nevertheless capable of pursuing and realizing an aim) or is selectively responsive in following the directions of the person (if any) who has induced the trance. Trance states may occur involuntarily and unbidden.

The term trance may be associated[by whom?] with hypnosis, meditation, magic, flow, and prayer. It may also be related to an earlier generic term, altered states of consciousness, which is no longer used in "consciousness-studies" discourse.

Trance in its modern meaning comes from an earlier meaning of "a dazed, half-conscious or insensible condition or state of fear", via the Old French transe "fear of evil", from the Latin transre "to cross", "pass over".[1]

Wier, in his 1995 book, Trance: from magic to technology, defines a simple trance (p.58) as a state of mind being caused by cognitive loops where a cognitive object (a thought, an image, a sound, an intentional action) repeats long enough to result in various sets of disabled cognitive functions. Wier represents all trances (which include sleep and watching television) as taking place on a dissociated trance plane where at least some cognitive functions such as volition are disabled; as is seen in what is typically termed a 'hypnotic trance'.[2] With this definition, meditation, hypnosis, addictions and charisma are seen as being trance states. In Wier's 2007 book, The Way of Trance, he elaborates on these forms, adds ecstasy as an additional form and discusses the ethical implications of his model, including magic and government use which he terms "trance abuse".

John Horgan in Rational Mysticism (2003) explores the neurological mechanisms and psychological implications of trances and other mystical manifestations. Horgan incorporates literature and case-studies from a number of disciplines in this work: chemistry, physics, psychology, radiology and theology.

The following are some examples of trance states:

Trance conditions include all the different states of mind, emotions, moods and daydreams that human beings experience. All activities which engage a human involve the filtering of information coming into sense modalities, and this influences brain functioning and consciousness. Therefore, trance may be understood as a way for the mind to change the way it filters information in order to provide more efficient use of the mind's resources.

Trance states may also be accessed or induced by various modalities and may be a way of accessing the unconscious mind for the purposes of relaxation, healing, intuition and inspiration. There is an extensive documented history of trance as evidenced by the case-studies of anthropologists and ethnologists and associated and derivative disciplines. Hence trance may be perceived as endemic to the human condition and a Human Universal. Principles of trance are being explored and documented as are methods of trance induction. Benefits of trance states are being explored by medical and scientific inquiry. Many traditions and rituals employ trance. Trance also has a function in religion and mystical experience.

Castillo (1995) states that: "Trance phenomena result from the behavior of intense focusing of attention, which is the key psychological mechanism of trance induction. Adaptive responses, including institutionalized forms of trance, are 'tuned' into neural networks in the brain and depend to a large extent on the characteristics of culture. Culture-specific organizations exist in the structure of individual neurons and in the organizational formation of neural networks."[3]

Hoffman (1998: p.9) states that: "Trance is still conventionally defined as a state of reduced consciousness, or a somnolent state. However, the more recent anthropological definition, linking it to 'altered states of consciousness' (Charles Tart), is becoming increasingly accepted."[4]

Hoffman (1998, p.9) asserts that: "...the trance state should be discussed in the plural, because there is more than one altered state of consciousness significantly different from everyday consciousness."[4]

According to Hoffman (1998: p.10), pilgrims visited the Temple of Epidaurus, an asclepeion, in Greece for healing sleep. Seekers of healing would make pilgrimage and be received by a priest who would welcome and bless them. This temple housed an ancient religious ritual promoting dreams in the seeker that endeavored to promote healing and the solutions to problems, as did the oracles. This temple was built in honor of Asclepios, the Greek god of medicine. The Greek treatment was referred to as incubation, and focused on prayers to Asclepios for healing. The asclepion at Epidaurus is both extensive and well-preserved, and is traditionally regarded as the birthplace of Asclepius. (For a comparable modern tool see Dreamwork.)

The Oracle at Delphi was also famous for trances in the ancient Greek world; priestesses there would make predictions about the future in exchange for gold.[5]

Stories of the saints in the Middle Ages, myths, parables, fairy tales, oral lore and storytelling from different cultures are themselves potentially inducers of trance. Often literary devices such as repetition are employed which is evident in many forms of trance induction. Milton Erickson used stories to induce trance as do many NLP practitioners.

From at least the 16th century it was held that march music may induce soldiers marching in unison into trance states where according to apologists, they bond together as a unit engendered by the rigors of training, the ties of comradeship and the chain of command. This had the effect of making the soldiers become automated, an effect which was widely evident in the 16th, 17th and 18th century due to the increasing prevalence of firearms employed in warcraft. Military instruments, especially the snare drum and other drums were used to entone a monotonous ostinato at the pace of march and heartbeat. High-pitched fifes, flutes and bagpipes were used for their "piercing" effect to play the melody. This would assist the morale and solidarity of soldiers as they marched to battle.

Joseph Jordania recently proposed a term battle trance for this mental state, when combatants do not feel fear and pain, and when they lose their individual identity and acquire a collective identity.[6]

The Norse Berserkers induced a trance-like state before battle, called Berserkergang. It is said to have given the warriors superhuman strength and made them impervious to pain during battle. This form of trance could have been induced partly due to ingestion of hallucinogenic mushrooms.

As the mystical experience of mystics generally entails direct connection, communication and communion with Deity, Godhead and/or god; trance and cognate experience are endemic. (see Yoga, Sufism, Shaman, Umbanda, Crazy Horse, etc.)

As shown by Jonathan Garb,[7] trance techniques also played a role in Lurianic Kabbalah, the mystical life of the circle of Moshe Hayyim Luzzatto and Hasidism.

Many Christian mystics are documented as having experiences that may be considered as cognate with trance, such as: Hildegard of Bingen, John of the Cross, Meister Eckhart, Saint Theresa (as seen in the Bernini sculpture) and Francis of Assisi.

Taves (1999) charts the synonymic language of trance in the American Christian traditions: power or presence or indwelling of God, or Christ, or the Spirit, or spirits. Typical expressions include "the indwelling of the Spirit" (Jonathan Edwards), "the witness of the Spirit" (John Wesley), "the power of God" (early American Methodists), being "filled with the Spirit of the Lord" (early Adventists; see charismatic Adventism), "communing with spirits" (Spiritualists), "the Christ within" (New Thought), "streams of holy fire and power" (Methodist holiness), "a religion of the Spirit and Power" (the Emmanuel Movement), and "the baptism of the Holy Spirit" (early Pentecostals). (Taves, 1999: 3)

Taves (1999) well-referenced book on trance charts the experience of Anglo-American Protestants and those who left the Protestant movement beginning with the transatlantic awakening in the early 18th century and ending with the rise of the psychology of religion and the birth of Pentecostalism in the early 20th century. This book focuses on a class of seemingly involuntary acts alternately explained in religious and secular terminology. These involuntary experiences include uncontrolled bodily movements (fits, bodily exercises, falling as dead, catalepsy, convulsions); spontaneous vocalizations (crying out, shouting, speaking in tongues); unusual sensory experiences (trances, visions, voices, clairvoyance, out-of-body experiences); and alterations of consciousness and/or memory (dreams, somnium, somnambulism, mesmeric trance, mediumistic trance, hypnosis, possession, alternating personality) (Taves, 1999: 3).

Trance-like states are often interpreted as religious ecstasy or visions and can be deliberately induced using a variety of techniques, including prayer, religious rituals, meditation, pranayama (breathwork or breathing exercises), physical exercise, sexual intercourse, music, dancing, sweating (e.g. sweat lodge), fasting, thirsting, and the consumption of psychotropic drugs such as cannabis. Sensory modality is the channel or conduit for the induction of the trance. Sometimes an ecstatic experience takes place in occasion of contact with something or somebody perceived as extremely beautiful or holy. It may also happen without any known reason. The particular technique that an individual uses to induce ecstasy is usually one that is associated with that individual's particular religious and cultural traditions. As a result, an ecstatic experience is usually interpreted within the context of a particular individual's religious and cultural traditions. These interpretations often include statements about contact with supernatural or spiritual beings, about receiving new information as a revelation, also religion-related explanations of subsequent change of values, attitudes and behavior (e.g. in case of religious conversion).

Benevolent, neutral and malevolent trances may be induced (intentionally, spontaneously and/or accidentally) by different methods:

Charles Tart provides a useful working definition of auditory driving. It is the induction of trance through the sense of hearing. Auditory driving works through a process known as entrainment.[citation needed]

The usage of repetitive rhythms to induce trance states is an ancient phenomenon. Throughout the world, shamanistic practitioners have been employing this method for millennia. Anthropologists and other researchers have documented the similarity of shamanistic auditory driving rituals among different cultures.

Said simply, entrainment is the synchronization of different rhythmic cycles. Breathing and heart rate have been shown to be affected by auditory stimulus, along with brainwave activity. The ability of rhythmic sound to affect human brainwave activity, especially theta brainwaves, is the essence of auditory driving, and is the cause of the altered states of consciousness that it can induce.[citation needed]

Nowack and Feltman have recently published an article entitled "Eliciting the Photic Driving Response" which states that the EEG photic driving response is a sensitive neurophysiological measure which has been employed to assess chemical and drug effects, forms of epilepsy, neurological status of Alzheimer's patients, and physiological arousal. Photic driving also impacts upon the psychological climate of a person by producing increased visual imagery and decreased physiological and subjective arousal. In this research by Nowack and Feltman, all participants reported increased visual imagery during photic driving, as measured by their responses to an imagery questionnaire.

Dennis Wier (https://web.archive.org/web/20060915232957/http://www.trance.edu/papers/theory.htm Accessed: 6 December 2006) states that over two millennia ago Ptolemy and Apuleius found that differing rates of flickering lights affected states of awareness and sometimes induced epilepsy. Wier also asserts that it was discovered in the late 1920s that when light was shined on closed eyelids it resulted in an echoing production of brainwave frequencies. Wier also opined that in 1965 Grey employed a stroboscope to project rhythmic light flashes into the eyes at a rate of 1025Hz (cycles per second). Grey discovered that this stimulated similar brainwave activity.

Research by Thomas Budzynski, Oestrander et al., in the use of brain machines suggest that photic driving via the suprachiasmatic nucleus and direct electrical stimulation and driving via other mechanisms and modalities, may entrain processes of the brain facilitating rapid and enhanced learning, produce deep relaxation, euphoria, an increase in creativity, problem solving propensity and may be associated with enhanced concentration and accelerated learning. The theta range and the border area between alpha and theta has generated considerable research interest.

Charles Tart provides a useful working definition of kinesthetic driving. It is the induction of trance through the sense of touch, feeling or emotions. Kinesthetic driving works through a process known as entrainment.

The rituals practiced by some athletes in preparing for contests are dismissed as superstition, but this is a device of sport psychologists to help them to attain an ecstasy-like state. Joseph Campbell had a peak experience whilst running. Roger Bannister on breaking the four-minute mile (Cameron, 1993: 185): "No longer conscious of my movement, I discovered a new unity with nature. I had found a new source of power and beauty, a source I never dreamt existed." Roger Bannister later became a distinguished neurologist.

Mechanisms and disciplines that include kinesthetic driving may include: dancing, walking meditation, yoga and asana, mudra, juggling, poi (juggling), etc.

Sufism (the mystical branch of Islam) has theoretical and metaphoric texts regarding ecstasy as a state of connection with Allah. Sufi practice rituals (dhikr, sema) use body movement and music to achieve the state.

Divination is a cultural universal which anthropologists have observed as being present in many religions and cultures in all ages up to the present day (see sibyl).[citation needed] Divination may be defined as a mechanism for fortune-telling by ascertaining information by interpretation of omens or an alleged supernatural agency. Divination often entails ritual, and is often facilitated by trance.

In Tibet, oracles have played, and continue to play, an important part in religion and government. The word oracle is used by Tibetans to refer to the spirit, deity or entity that enters those men and women who act as media between the natural and the spiritual realms. The media are, therefore, known as kuten, which literally means, "the physical basis".

The Dalai Lama, who lives in exile in northern India, still consults an oracle known as the Nechung Oracle, which is considered the official state oracle of the government of Tibet. He gives a complete description of the process of trance and possession in his book Freedom in Exile.[13]

Convergent disciplines of neuroanthropology, ethnomusicology, electroencephalography (EEG), neurotheology and cognitive neuroscience, amongst others, are conducting research into the trance induction of altered states of consciousness resulting from neuron entrainment with the driving of sensory modalities, for example polyharmonics, multiphonics, and percussive polyrhythms through the channel of the auditory and kinesthetic modality.

Neuroanthropology and cognitive neuroscience are conducting research into the trance induction of altered states of consciousness (possibly engendering higher consciousness) resulting from neuron firing entrainment with these polyharmonics and multiphonics. Related research has been conducted into neural entraining with percussive polyrhythms. The timbre of traditional singing bowls and their polyrhythms and multiphonics are considered meditative and calming, and the harmony inducing effects of this tool to potentially alter consciousness are being explored by scientists, medical professionals and therapists.

Scientific advancement and new technologies such as computerized EEG, positron emission tomography, regional cerebral blood flow, and nuclear magnetic resonance imaging, are providing measurable tools to assist in understanding trance phenomena.

There are four principal brainwave states that range from high-amplitude, low-frequency delta to low-amplitude, high-frequency beta. These states range from deep dreamless sleep to a state of high arousal. These four brainwave states are common throughout humans. All levels of brainwaves exist in everyone at all times, even though one is foregrounded depending on the activity level. When a person is in an aroused state and exhibiting a beta brainwave pattern, their brain also exhibits a component of alpha, theta and delta, even though only a trace may be present.[14]

The University of Philadelphia study on some Christians at the Freedom Valley Worship Center in Gettysburg, Pennsylvania, revealed that glossolalia-speaking (vocalizing or praying in unrecognizable form of language which is seen in members of certain Christian sects) activates areas of the brain out of voluntary control. In addition, the frontal lobe of the brain, which monitors speech, significantly diminished in activity as the study participants spoke glossolalia.[15] Dr. Andrew B. Newberg, in analysis of his earlier studies as opposed to the MRI scans of the test subjects, stated that Buddhist monks in meditation[16] and Franciscan nuns in prayer[17] exhibited increased activity in the frontal lobe, and subsequently their behaviors, very much under voluntary control. The investigation found this particular beyond-body-control characteristic only in tongue-speakers (also see xenoglossia).

Go here to read the rest:

Trance - Wikipedia

Prince Harry was first to drop L-bomb, left ‘in a trance’ after first date with Meghan Markle, new book claims – Newshub

The Duke of Sussex was reportedly left "in a trance" after his first date with the former Suits actress, and while the couple didn't kiss that night, they were "immediately obsessed" with each other, according to the new book Finding Freedom.

The biography by royal commentators Omid Scobie and Carolyn Durand says Harry sipped a beer while Meghan drank a martini at their first rendezvous, after which she told her friends 'this could have legs'.

The pair allegedly met again the very next night at the same venue - Dean Street Townhouse in Soho, London. Three months later, Harry was said to be the first to drop the L-bomb to Meghan, who immediately said it back.

The authors of Finding Freedom claim to have spoken to more than 100 sources, including 'close friends of Harry and Meghan' as well as royal aides and palace staff. The book promises that every piece of information included has come from at least two sources.

Read more here:

Prince Harry was first to drop L-bomb, left 'in a trance' after first date with Meghan Markle, new book claims - Newshub

Discover: ‘You’re getting sleepy’ the amazing science of hypnosis – Sudbury.com

Trance states can be fun when youre on stage, but they can also have profound effects in relieving pain and changing behaviour

When you hear the word hypnosis, you may be immediately reminded of that stage show you saw, and the man that had a great time clucking like a chicken on command. Perhaps you think of being out of your own mind, unable to control your body, and something you never want to experience.

But the thing is, you probably already have. Ever fallen into a trance watching the snow come at the windshield? So engrossed in a book or movie that you forget the world youre in, felt the relaxation of a flickering flame, or even, the calm meditation of the Zamboni making its rounds?

And you know everybody watches the Zamboni you cant take your eyes off it.

All of these times, you have been in whats really, at its base level, a trance. It is this state whether it is an altered state of consciousness or simply a relaxed one (this is still up for debate) that allows the power of suggestion to work to its true potential. And in the right hands, that could mean that changing your perception of the world while in this state.

Hypnotherapy, the practice of accessing the subconscious mind in order to change behaviour, has been around for some time more than 200 years really. And though it began as a pseudoscience, without much in the way of standard practice and some outlandish theories to say the least hows the idea of disease called animal magnetism featuring an internal liquid magnetic force it has now been shown not only to have an effect on the subconscious mind, but a measureable one.

A landmark study in 1999 by Pierre Rainville from the University of Montreal tested pain response in conjunction with hypnotism. In the study, hypnotized participants briefly placed their left hand in water one heated to a painful 116 degrees Fahrenheit (46 degrees Celsius) and the other left at room temperature. Some participants were instructed that as they put their hand in the water they may feel some pain, but not a bothersome amount. For instance, if the usual pain register would be a ten, then they might only feel it as a five.

The participants had neurological scans while the test was happening, and there were remarkable results. Those who put their hand in the 116-degree water but were told the pain would be less showed less activity in their brains. Specifically, less activity in the anterior cingulate cortex, associated with pain processing.

A more recent Stanford university study in 2016 found changes in the brains functions as well. Dr. David Spiegel, professor and associate chair of psychiatry and behavioral sciences at Stanford, and his colleagues screened 545 healthy participants and found 36 people who consistently scored high on tests of hypnotisability (your ability to follow orders and pay careful attention), as well as 21 control subjects who scored on the extreme low end of the scales.

Using Functional Magnetic Resonance Imaging (FMRI) to measure brain activity, each person was scanned: while resting, while recalling a memory, and during two hypnosis sessions.

What they found and what they found only in the patients who scored highest on the hypnotisability test, and only while they were in one of the two hypnosis sessions was three distinct changes.

First, they saw a decrease in activity in the dorsal anterior cingulate, part of the brains salience network, which detects behaviorally relevant stimuli and co-ordinates the brain's neural resources in response to these stimuli.

Then, an increase in connections between two other areas of the brain the dorsolateral prefrontal cortex and the insula. Spiegel describes this as a brain-body connection that helps the brain process and control whats going on in the body.

Finally, Spiegels team also observed reduced connections between the dorsolateral prefrontal cortex and the default mode network, which includes the medial prefrontal and the posterior cingulate cortex.

This decrease in functional connectivity could potentially be the disconnect between someones actions and their awareness of their actions.

When it comes to weight loss with hypnotherapy, small scale studies are showing it could be a more effective long-term weight loss tool, and highly complementary to other behavioural changes. Other small studies seeking to show if hypnosis can help with smoking, treat a drug addiction, or even self-hypnosis in order to avoid relapse have found it is a very viable therapy.

One of the most fascinating aspects though, is hypnotherapys potential within healthcare.

There is beginning research into hypnotherapy as a complement in treating Pediatric Crohns Disease.

As well, Montreal Childrens Hospital Interventional Radiology department took part in a pilot project to better understand medical hypnosis. More than 120 children and teens have now undergone medical hypnotism, and the results are astounding.

Patients who were hypnotized prior to procedures rated their discomfort at an average 1.4 out of 10 for pain those without rated it a 5.4. The use of medical hypnotherapy is now resulting in the use of less or no sedation for procedures that previously depended on the time, cost and risk of anesthesia. As well, as children are known to be medical wigglers, the hypnotic state is allowing the medical professionals to better and more easily perform the required medical procedures.

Imagine making the life of a child in pain better, without needing to do more than to teach them to relax.

But if youre a skeptic, you might still wonder about the placebo effect. Well, youre not wrong. The thing is, the placebo effect can be quite healing.

In her book, Cure: A Journey Into the Science of Mind Over Body, journalist and author Jo Marchant details the placebo effect, and the fact that the brain is still responding in the desired capacity. For instance, she notes that a placebo painkiller can actually trigger the release of the same pain-relieving endorphins that pain medication would. Or patients with Parkinsons disease can take a placebo pill and still feel the same release of dopamine that they would if they took their actual medication.

That is, of course, unless the patient knows its a placebo. That is one of the stickier issues when it comes to studying the effects of hypnosis. In order to accurately capture it, the study participant cant know its happening. And that can make for an ethical dilemma.

Using the method as treatment however, requires you in the drivers seat, says Gilles Brideau, Sudbury-based registered psychotherapist and practitioner of hypnotherapy since 2002.

What hypnosis is really like, he says, is like we're driving in a car, and I have a map. While he can gently advise you that your turn is coming up because his map says so you can still drive right past. Its this choice, this free will, which will help your experience with the process as well.

According to Brideau, the success of hypnotherapy comes from your brains inability to distinguish what is happening now, and what you are imagining is happening.

Im sure youve had a dream, says Brideau, a very vivid dream in which you were being chased. If you wake up and you do a carotid (pulse) check, your heart would be racing. But what were you doing? Laying down, resting. We get a physiological response to an action that wasnt taking place, because your brain perceived it to be real.

Its this power to bring the brain into a moment that hasnt happened yet that allows for help during medical procedures, hypnobirthing, even upcoming medical procedures that are causing anxiety for the prospective patient.

The session would begin with some questions, mostly geared to your desired outcomes. Then, some helpful tool of distraction. A pair of glasses that flash small lights in your eyes at a quicker pace before slowing, as well as a noise-canceling headphones that only allow the chosen musical cues and the voice of Brideau to enter. My clients laugh and say youre in my head.

Its then that Brideau uses not only his training as a psychotherapist to determine his plan of action, but also his background in cognitive behavioral therapy, and other modalities. While its easy to get someone into a trance, the rest takes a skillful hand.

Then, its a matter of practice makes perfect. If you are terrified of airplanes, your time spent taxiing should not be the moment where you try to deal with the fear for the first time. With hypnotherapy, you could begin your journey 10-20 times before setting foot in the airport, simply by practicing with a hypnotherapist to help to access a calm state, and listening to their hypnotic suggestions.

Suggestions are made based on the desired outcome of the client, says Brideau, but if it is not their true desire, it wont work, says Brideau.

So if I get a wife who would really like her husband to quit smoking, but he doesnt want to, its not going to work, he said.

The outcome is discussed in detail in advance of any sessions, and very often scripted according to protocols from other eminent sources. There is one for Irritable Bowel Syndrome (IBS) that Brideau often employs, as well as also working with the clients to refocus on positive outcomes. Its not I want to be 150 pounds, says Brideau. Its about what is going to happen, will you be able to stop eating and feel full sooner, will you be able to choose foods that are better for your health.

And while there are no regulatory bodies governing hypnotherapy, the training in other areas will tell you when you have found someone you can trust. Hypnotherapy should be but one tool of an educated professional.

But if youre still worried about being made to bark like a dog, know that hypnosis cannot make you do anything youre not open to. When you see someone acting like a fool onstage, know that they are having a great time, because that was their desired outcome.

You go to a stage show to have fun, says Brideau. A lot of times, because I've done a stage show, it's kind of like I can't believe I'm doing this but I don't really care. Because you're aware the whole time. In that moment, I want to live, I want to have a good time, I want to enjoy myself right now.

So whether you are interested in hypnobirthing, help for a medical procedures, easing fears or anxieties, trouble with relaxation, smoking, and weight loss even animal noises then a hypnosis session could be of interest to you. While there are no large-scale, long-term studies at the moment, there is the beginning of fascinating research into the field, and a new understanding of the brain.

Jenny Lamothe is a freelance writer, proof-reader and editor in Greater Sudbury. Contact her through her website, JennyLamothe.com.

See the original post here:

Discover: 'You're getting sleepy' the amazing science of hypnosis - Sudbury.com

Blackpool nurse is a hit as guest DJ on Dave Pearce Delirium show as a thank you to key workers – Blackpool Gazette

Nurse Chris Gorse who played a DJ guest set for Dave Pearce Trance Anthems

Father-of-two Chris, who turned 50 last month, was surprised by wife Janet with the chance to play the guest DJ mix on Pearces Delirium slot after writing to him and telling him of Chriss dream.

The amateur DJ from Cleveleys said Janet was stunned to receive a response from the former Radio 1 DJ inviting Chris to record a set, as a thank you for his work during the Covid crisis.

He said:Janet handed me a letter the day of my birthday with this opportunity and I couldnt believe it. To play in the club alongside someone of Daves calibre has always been an ambition, to have the chance to do it even online was just unreal.

He is a genuinely lovely bloke who really champions NHS causes and a couple of months back supported Blue Skies so it was really touching.

I then had to get the decorators in to sort the room quick as I had cleared it out of all my decks and needed to set it back up!

Chris played a 25 minute set of some of his most meaningful and favourite trance anthems and then sent the track list to Pearce for approval. The set can now be listened to on his official Dave Pearce Facebook page.

Chris, grandad to Archie and Alfie, even recorded a voiceover with a special shout-out to his team at the Royal Lancaster Infirmary where he works.

He added: On the night it was a real family, team effort as my daughters Clair and Cody set up laptops so we could respond to everyone tuning in from all over the world - it was great to see people enjoy it.

DJ Dave Pearces Trance Anthems show streams every Sunday via his official Facebook page http://www.facebook.com/DavePearceOfficialPart-time amateur DJ Chris Gorse was given the guest DJ slot by Pearce as a thank you to Keyworkers through the Covid 19 crisis.

Chris who has been playing his decks for 21 years said: It is my passion and a way for me to just switch off from it all - I can close my eyes and transport myself anywhere in the world.

It was a fantastic experience to put my own imprint on a guest set and work with a DJ who really flies the flag for trance music.

See the rest here:

Blackpool nurse is a hit as guest DJ on Dave Pearce Delirium show as a thank you to key workers - Blackpool Gazette

Ray Fisher has revealed his one request for the Justice League Snyder Cut – Flickering Myth

Cyborg actor Ray Fisher has revealed his one request for Zack Snyders Justice League.

Ray Fisher, who plays Cyborg in the DCEU, has been very vocal about his excitement for Zack Snyders Justice League, hoping that it will right many of the wrongs of Joss Whedons theatrical version.

One thing that he wants fixed more than anything, however, is a mention in the credits for someone who was left out from the theatrical release. Taking to Twitter, Fisher said:

Despite my asking on multiple occasions, my barber (Wayne Nembhard) was not credited in any capacity for his work on the theatrical version of Justice League.

Wayne worked with us for the ENTIRE principle photography process (8 months) and the majority of the reshoots.

SEE ALSO: Zack Snyder on Justice Leagues position in the DC Multiverse and his take on Superman

Wayne took whatever time was asked of him away from his successful businessa unisex barber salon called Extreme Cutz in St. Albans, UKto work with us.

Too my knowledge, he was the only Black man to ever grace the hair and makeup trailer.

It broke my heart (as I know it did Waynes) to watch the credits roll and not see his name appear in any way.

When Zack told me about the Snyder Cut being released, I only had one request: that Wayne be given credit for his work.

Zack was shocked that Wayne wasnt credited in the theatrical version and assured me that Wayne would absolutely be given credit in Zack Snyders Justice League.

Despite my asking on multiple occasions, my barber (Wayne Nembhard) was not credited in any capacity for his work on the theatrical version of Justice League.

Wayne worked with us for the ENTIRE principle photography process (8 months) and the majority of the reshoots.(1/4) https://t.co/WC178DXvan

Ray Fisher (@ray8fisher) July 21, 2020

While this isnt a change any of us fans would notice, it certainly sounds like a good cause Fisher is pushing for. So keep an eye out for Wayne Nembhard when those credits start to roll.

InJustice League, fueled by his restored faith in humanity and inspired by Supermans selfless act, Bruce Wayne enlists the help of his newfound ally, Diana Prince, to face an even greater enemy. Together, Batman and Wonder Woman work quickly to find and recruit a team of metahumans to stand against this newly awakened threat. But despite the formation of this unprecedented league of heroesBatman, Wonder Woman, Aquaman, Cyborg and The Flashit may already be too late to save the planet from an assault of catastrophic proportions.

Justice Leagueis directed by Zack Snyder and features Henry Cavill as Superman, Ben Affleck as Batman, Gal Gadot as Wonder Woman, Ray Fisher as Cyborg, Jason Momoa as Aquaman, Ezra Miller as The Flash, Amy Adams as Lois Lane, Jeremy Irons as Alfred Pennyworth, Diane Lane as Martha Kent, Jesse Eisenberg as Lex Luthor, Connie Nielsen as Queen Hippolyta and Robin Wright as General Antiope, J.K. Simmons as Commissioner Gordon, Amber Heard as Mera, Ciaran Hinds as Steppenwolf and Ray Porter as Darkseid.

Follow this link:

Ray Fisher has revealed his one request for the Justice League Snyder Cut - Flickering Myth

Doom Patrol Is a Refreshing Ally For the Queer Community, and We Love It – POPSUGAR

If you squealed with joy during Joe's emphatic, heart-aching monologue in The Old Guard, Doom Patrol should be next on your watchlist. Originally debuted by DC Universe last year, the outlandish superhero series was renewed by HBO Max for its second season, becoming another addition to the new streamer's slate of originals.

First and foremost, Doom Patrol is amazing and more people should be talking about it. With leading roles filled by the smoldering Matt Bomer, '90s icon Brendan Fraser, Orange is the New Black's Diane Guerrero, and former James Bond himself, Timothy Dalton, the cast is already reason enough to watch. If the reputation behind the names isn't a big enough draw, the show gives audiences something critics of superhero films have long been asking for: queer representation.

As an oddball mixture of the enthralling, morose stakes indicative of the superhero genre coupled with wildly camp characters and story elements, Doom Patrol is an irreverent, genre-blending original. Moaning sex ghosts, a hero whose flex-activated telekinesis can send a shock wave of orgasms, and a rollerskating time villain it's all on the table. Danny The Street, is however, the most peculiar and perfect of them all.

Danny the Street is a living gender-queer street with the power to teleport themselves and their residents to any location in the world (possibly universe). They communicate through street signs, napkins, neon signs, and anything else they can create lettering on. First introduced in "Doom Patrol #35" in 1990 by writer Grant Morrison, Danny was originally a cross-dressing transperson (referred to in the comics as a "transvestite") who offered himself as a safe haven people who either weren't accepted by or didn't feel at home in society.

The term "transvestite" alone is problematic and dated, but the show creators sought to maintain Danny's queerness in the series adaptation, resulting in their much-needed evolution to non-binary. Season one's episode eight, "Danny Patrol," is their first introduction on the series, and follows heroes Cyborg (Joivan Wade) and Larry Trainor (voiced by Matt Bomer) in their fight to protect Danny and Danny's residents, cutely referred to as Danizens, from the evil Bureau of Normalcy.

Throughout the episode, Danny and fabulous transgender woman Maura Lee Karupt reiterate the importance of celebrating, and most importantly respecting, people's differences. Danny and Maura Lee's teachings really hit home for Larry, who struggles to find pride in his homosexuality. Embellished with a drag show ending, Pride.com called the episode "the queerest episode of television in 2019." In respect to his role, Matt Bomer told Digital Spy, "Larry is one of the most three-dimensional, fully [realized] gay characters I've ever played. As much as it's a fun superhero show, Doom Patrol is really about the human condition."

In a literal sense, Doom Patrol's queer characters bring the queer representation desperately craved in superhero franchises, but that isn't where the representation ends. Like all superhero stories, the heroics aren't the real focus of the project. Sure, we all loved seeing Iron Man take on Thanos in his super suit, but it was his development from arrogant, self-absorbed rich kid to self-sacrificing mentor that kept us emotionally attached.

Through the vehicle a superhero adventure, Doom Patrol ultimately tells the story of outsiders laboring to find joy in the differences that cast them out from society's acceptance. Narrated in a modernized camp style reminiscent of Joel Schumacher's 1997 flop-turned-cult-hit Batman & Robin, the series uses queer characters to investigate a trial in life that is inherently relatable to the queer experience.

See the article here:

Doom Patrol Is a Refreshing Ally For the Queer Community, and We Love It - POPSUGAR

‘Since I arrived, we would be fourth’ – Mourinho pleased with Spurs’ progress towards Europa League spot – Goal.com

Tottenham ended the season on a high after sealing a sixth-place finish, having sat in 14th at the time of Mauricio Pochettino's departure

Jose Mourinho hailed Tottenham's push to seal a spot in the Europa League as the Portuguese manager made sure to point out how much the club has improved since he took over.

Spurs locked up a sixth-place finish with a point on Sunday, as Mourinho's side finished the Premier League season with a 1-1 draw against Crystal Palace.

Despite ending the season with a draw, Tottenham did enough to climb all the way to sixth place and seal an automatic spot in the Europa League.

Article continues below

When Mourinho took over following Mauricio Pochettino's dismissal, Spurs sat in 14th place, having earned just 14 points from as many matches in the Premier League.

Harry Kane scored the opening goal for Spurs just 13 minutes on, but a Jeffrey Schlupp goal early in the second half was enough for the two sides to split the points.

And, although Mourinho admitted the performance wasn't quite what the club hoped for, Sunday's result did seal a positive end to what was an overall disappointing campaign.

Under the Portuguese boss, the club completed quite the turnaround, with Mourinho pleased with the progress made so far even if there was a long way to go.

The season was crazy, since they played the Champions League final it has been up and down and really hard," Mourinho told Sky Sports.

"We, in this group of matches managed to get results and to perform. Not today, it was not the best. But in this period we played well, get results and be solid to put ourselves in the position to get in the Europa League

"From a personal point of view I'm happy because since I arrived we would be fourth which is good with all the problems we had."

Now, with European football secured, Mourinho can look ahead towards continuing to make his mark on the Spurs squad.

The club faces several departures, with Jan Vertonghen and Michel Vorm set to leave, but Mourinho says that he expects to improve the squad this summer.

"When all the players are available we showed in this last period where we belong," he said at his post-match news conference.

"After lockdown we finished third or fourth in the table. That is where we belong. I want to have my team, my players, not a medical room full of players, a pitch full of players.

"We want to keep our very good players and after that improve the squad. Are we going to buy 10 players. No? Are we going to pay 100 million ($125m) for a player? No.

"But let's see. The market is very strange. I don't know if we will start working pre-season with any new players or something that is going to go through the whole period.

"We are going to keep the structure of the team because we have absolutely no interest in selling our best players.

"I enjoy working with [chief scout] Steve Hitchen and we are very connected with [Daniel] Levy and the board.

"We're going to do what is possible and hopefully next season we can give the fans a very good season."

See more here:

'Since I arrived, we would be fourth' - Mourinho pleased with Spurs' progress towards Europa League spot - Goal.com

Mercy Quaye: Achieving police accountability and the cost of progress – CT Insider

Change aint easy. Especially when policing is involved.

After sitting for nearly 24 straight hours in a special session last Thursday into Friday, two state representatives, Jesse MacLachlan, R-35, and Quentin Phipps, D-100, used the same word to describe their feeling immediately following the ordeal: Raw.

House Bill 6004: An Act Concerning Police Accountability attracted hundreds of testimonies from across the state and resulted in an eight-hour discussion early Friday morning. The bill ultimately passed the House with an 86-58 vote. But the tied vote on the amendment to strike the qualified immunity portion of the bill is far more interesting to me.

That tie, in part, was due to hearts that changed after the killing of George Floyd.

After that incident, I got a call from Representative MacLachlan from the shoreline and he asked how he could help, Phipps said on a phone call with me just a couple of hours after the vote. Having bonded over their Christian faith in the past, Phipps said he welcomed the call; its just that At the time I didnt think much of it, but he made the right vote today and Ill never forget that kind of bravery.

MacLachlan was the only Republican vote against the amendment to repeal qualified immunity. And after spending the last several weeks working diligently to understand the issues, his vote Thursday stood in sharp contrast from his previous votes on police accountability. The reason for that, he said, was he wanted to get it right.

On a call Friday morning after the vote, MacLachlan sounded heavy, weighted by the events of the previous night. Through a solemn conversation, he walked me through his commitment to understanding the issues, especially issues from communities of which hes not a part.

For him, making a well-informed decision meant reaching out for guidance.

After (voting against the previous police accountability bill) he asked himself why, Sen. Gary Winfield, D-10, said. I think what he realized was that he was operating as a part of a unit. And even though he was hearing the arguments from people with lived experiences and knew it made sense, he still voted against it. This time, he sat with the (Black and Puerto Rican Caucus) and came to hear from them.

MacLachlan said his path to understanding the issues starting with emailing the BPRCs aide to set up a meeting. That meeting quickly resulted in a Zoom call. There he sat, he listened, he empathized and the only commitment he made was to continue to do so.

He maintains that it wasnt perfect, but it was the right thing to do.

I strongly believe that every single member of the state legislature is doing what they believe is right, he said in an emailed statement. Enhancing the safety, security, and freedoms of all Connecticut residents is my top priority. After careful consideration, I believe that the bill we voted on today effectively bolsters both public safety and accountability.

While MacLachlan was the only Republican vote against the amendment, the weight of that vote only mattered because of the 15 Democratic votes in favor of it. To Winfield, that split is a clear indication that the issue didnt fall neatly on party lines.

I think those are cultural, racial, experiential lines, he said. They say all politics are local politics, but I think all politics are identity politics, because wherever I go Im a Black man, and that has everything to do with my experience.

When he brings forth or votes on a bill, Winfield said he tries to remember that his actions as a legislator arent for him.

I dont have time to luxuriate in the victory because I still have to fix the problems with housing, incarceration and education access, he said. If youre really doing this work you dont get a break. My work has always been about the people I represent. If its ever about me and no one else, then Im not doing the right work.

This time, his and the work of several Black legislators during discussion on the bill meant offering their traumatic policing stories up in a prostration-like demonstration to prove imperative for the bill.

I do it hoping that my pain is enough for you to recognize that Im human like you are knowing that its often not, he said. As much as I dont want to do it, given that we need to win, I know I need to.

As it stands, the bill includes much of the original language rolling back qualified immunity and allows civil lawsuits to move forward against police officers in state court. This key piece, coupled with a number of the other police accountability measures Winfield has proposed and championed, will go a long way toward addressing concerns from evidently over-policed Black and brown communities.

Its important because when the system fails us and it always does we need the power to say, Im going to court, he said.

Opponents of the bill have contested the removal of qualified immunity, asserting that is isnt a fair measure and will punish officers when they inadvertently commit a crime. But when civilians inadvertently commit crimes, arent they held accountable? People in uniforms, with weapons and the power to apprehend people when they so please, should be held to the same standard if not higher.

Getting this bill over the finish line in the House required emotional sacrifices and potentially political ones, as well. After posting a Facebook status detailing the reason he voted for the bill and against the amendment, MacLachlans post was rushed with comments that people will pull their support of him in the next election and joked about leveraging qualified immunity to sue him for his support of the bill.

He maintains that it wasnt perfect, but it was the right thing to do.

Certainly there were parts in the bill that needed to be reworked or else really good police officers would have (been) hurt, he said. And we incorporated a number of the changes that would be needed to protect officers from an onslaught of lawsuits because we dont want officers to be driven from their post. But it still gives communities an avenue to protect themselves. The bill was about keeping all the members of all our community safe.

We dont often celebrate people for a change of heart or doing something just. But for me its important to give people an example of what doing the right thing can look like, particularly when doing the right means going against a political machine and an entire party or profession.

MacLachlan and Rep. Anthony Nolan, D-39, who is a New London police officer, are both likely to see an incredible backlash in response to their votes in favor of the bill, which is slated for a vote before the Senate this week. That, Winfield said, is the cost of progress.

Just because something is the right thing to do doesnt mean its as easy as we think it is.

Mercy Quaye is a social change communications consultant and a New Haven native. Her column appears Mondays. Contact her at @Mercy_WriteNow and SubtextWithMercy@gmail.com.

See the original post:

Mercy Quaye: Achieving police accountability and the cost of progress - CT Insider

Steve Stephens: Home continues to be work in progress and thats OK – The Columbus Dispatch

I started building my house almost 30 years ago and have now come to grips with the fact that it will never be finished.

I was personally involved with the project well before construction began.

The moment I first saw the view from the bluff above the Little Darby Creek, where my future house would grow, I had an epiphany like Brigham Young first espying the future site of Salt Lake City (with fewer religious implications): This is the place.

I labored on the work from the beginning, eventually bidding adieu to my contractors after a couple of years, planning to tie up the loose ends on my own. Im still tying.

Little projects that could be put off, were, to be eventually, more or less, tackled and finished more or less. So there was never a day when I was handed the keys and presented, Bob Vila ex machina, with a finished product.

Until relatively recently, I never thought of my house as anything but new. I remember the day just a few years ago that a salesman called seeking to sell me replacement windows.

"But my house still isnt even finished!" I exclaimed.

It was, at the time, more than two decades old.

Im still swimming toward the finish line, but the current against me grows swifter even as I do not.

Although ideas are always being added to my to-do list, now Im prioritizing repairs over those new projects that have been put off, some for nearly 30 years.

Appliances have come and gone and come and gone again.

The HVAC has chugged along like a champ, needing, like me, only occasional minor repair. But I have to imagine that it, like me, is feeling slightly less peppy than in 1992.

And thoughts of my deep-well pump going kaput no longer haunt only my dreams, but now my budgeting, too.

Im even planning can it be possible? to replace, in the next year or so, that new, 28-year-old roof that I helped put on. (This time, I will not be going up there myself.)

Ive found, however, that renovation can be almost as satisfying as addition.

My wife and I recently remodeled our kitchen, a rewarding project. And since were planning to keep the place until were carted out horizontally, we dont have to worry about the tastes of potential buyers. If we want to place decorative terracotta medallions salvaged from the frieze of an old school in the wall above the refrigerator, we can do it. (And we did.)

As time moves on, of course, the temporal imperatives of some projects grow. If Im going to remodel my teenagers bathroom which is now twice their age I need to tackle the project very soon if I want them to enjoy the results as anything but returning visitors, and if I want them to help with the heavy lifting.

Truth be told, I also have furtive thoughts that some day one of my offspring will want to take over the house, the dream thats been growing for nearly 30 years now on the little bluff over the Little Darby.

I have the to-do list ready.

Steve Stephens is the Dispatch home reporter. Email him at sstephens@dispatch.com or follow him on Twitter @SteveStephens.

Continued here:

Steve Stephens: Home continues to be work in progress and thats OK - The Columbus Dispatch

Yellowjackets Looking for Constant Progress on the Field – Zip06.com

Although the East Haven boys soccer team only won one game last year, Head Coach Mike Papantonio started to see the Yellowjackets improve on the field as the season unfolded. As East Haven looks toward a new season, Coach Papantonio is hoping that his returning athletes learned from a lot from last years leaders and will continue to progress on the pitch.

The Easties featured eight seniors on their roster in 2019, including captains Telmo Romero, Diego Ortiz, and Alejandro Sanchez. Papantonio said that all three captains provided an example of what this years team should be striving for.

We had a strong trio of senior captains last year. I asked a significant amount from those kids, and they delivered. They showed up every day and they worked, said Papantonio. For the kids that are coming back this year, they watched that happen. They struggled throughout, and everyone who played last year wants to return this year. It just speaks to the leadership and the groundwork that those guys laid. Those guys set the bar high, and this team will have to work hard to meet it.

Papantonio has yet to name captains for this year as he awaits more information about the potential of a fall season. However, when it comes to leaders, East Havens coach is expecting a big year both on and off the field from senior defender Matthew Torres and senior goalie Asa Myers. Papantonio said that Myers is a player who the Yellowjackets are going to lean on, and added that Torres has been crucial in terms of communicating with the team and setting up practices.

The Yellowjackets senior class also features midfielder Junnyor Torres, midfielder/defender Gianmarco Presiado, and defender/forward Leandro Soto-Molina. Victor Calvillo, who plays forward; and Lewis Agudelo, a center back, are also seniors on the team.

East Havens junior class includes Thanh Ngo and Brayan Crespo, who both play forward and midfielder; along with midfielders Erick Caguana, Merab Nabi, Ethar Al-hawari, Kevin Phan, and Frank Annunziato; and defender Victor Rolon.

Sophomore Christofher Torres will also be returning to the pitch this fall. Torres started every varsity game as a freshman for Coach Papantonios squad.

Were moving in the right direction. Looking at win and loss records are not the correct way to evaluate our performance. The way we ended the season kind of on an uptick, I think we will carry some of that momentum into this year, Papantonio said. Everything that Im hearing from the kids is all positive. They want to get back and have another crack at it. Weve got a really good group.

East Haven began its conditioning program two weeks ago. Every player gets his temperature checked before each practice and must adhere to social distancing guidelines, wearing masks when not in action.

The Yellowjackets have been doing a lot of running and focusing on getting stronger during their conditioning sessions. Whether it be one-mile runs or full-field sprints, Coach Papantonio wants to make sure that his players are ready to deal with the rigors of a soccer season and have enough fuel in the tank to last through an 80-minute game.

The goal is to be able to play the full 80 minutes game in and game out, said Papantonio. Maintaining that level of pressure and intensity for 80 minutes is really my goal. To do that, were going to need numbers, and were going to need to be physically and mentally tough, which is the biggest hurdle.

Coach Papantonio remains hopeful that the Easties will get a chance to take the field and see the dividends of all the hard work they did throughout the offseason. Papantonio wants his players to keep working hard to develop their own culture and build a winning program at East Haven.

Theres a handful of games where Im not expecting to just be competitive. Im expecting to come away with a result, Papantonio said. I want to be in a position where, in the last 20 minutes of the game, were playing for a result, not for pride anymore.

2020 East Haven Boys Soccer Schedule

Thursday, Sept. 10: at Branford at 6:30 p.m.

Tuesday, Sept. 15: at Notre Dame-West Haven at 3:45 p.m.

Tuesday, Sept. 22: vs. Cheshire at 4 p.m.

Thursday, Sept. 24: at Lyman Hall at 3:45 p.m.

Saturday, Sept. 26: vs. Guilford at 10 a.m.

Wednesday, Sept. 30: vs. North Haven at 6 p.m.

Monday, Oct. 5: vs. Branford at 6 p.m.

Wednesday, Oct. 7: vs. North Branford at 6:30 p.m.

Friday, Oct. 9: vs. Notre Dame-West Haven at 6 p.m.

Saturday, Oct. 17: at Cheshire at 6 p.m.

Monday, Oct. 19: vs. Lyman Hall at 7:30 p.m.

Wednesday, Oct. 21: at Guilford at 3:45 p.m.

Saturday, Oct. 24: at North Haven at 5 p.m.

Monday, Oct. 26: at Career-Hillhouse at 3:45 p.m.

Wednesday, Oct. 28: vs. Platt Tech at 6 p.m.

Go here to read the rest:

Yellowjackets Looking for Constant Progress on the Field - Zip06.com

Heres How Corporate Leaders Can Make Meaningful Progress On Diversity And Inclusion – Forbes

Business leaders can take the initiative on promoting diversity and justice.

When the tragic murder of George Floyd set off protests against racism and injustice across the world, many leaders in business came forward to declare they stood by the African-American community and would work towards eliminating bias and discrimination within their own organizations. Many publicly stated Diversity and Inclusion (D&I) initiatives would become embedded within their organizational cultures to remedy what is a glaring lack of diversity in the upper echelons of the corporate universe. Across every industry, companies can do better. And the same goes for professional associations.

As the CEO of IMA (Institute of Management Accountants), my focus is on the finance and accounting profession, and how D&I can be promoted among the finance and accounting professionals who are the talent pipelines of organizations. Our membership comprises those currently holding senior leadership positions as well as those poised to succeed them. IMA has built D&I not only into its own organizational structure but into its overall mission in a holistic, all-encompassing way. We have made great strides, including having more than 50% female representation on our board for the first time in our long history.

I want to focus here not on IMAs own activities, but on what we have learned about best practices with regard to promoting D&I within organizations. The lessons we have drawn can help equip companies especially their accounting and finance leaders with the tools they need to successfully recruit and retain diverse talent. This is increasingly important in an environment where failing to do so is effectively leaving valuable skills and perspectives on the table, in addition to inviting reputational damage.

At IMA we recently published a synopsis of these best practices and how to implement them within organizations. It is called the Diversity and Inclusion Toolkit, which can serve as a guide for any employee or executive who wants to jumpstart a D&I initiative within their own organization. I want to emphasize this guide was conceived and developed before the protests. By proactively addressing D&I, IMAs organizational culture made talking about D&I issues safe for employees and constructive for the organization as a whole. Subsequent events have only reinforced the need for D&I initiatives to be a part of business operating models.

The challenge of D&I is straightforward: despite public commitments and in most cases earnest belief, there is still a lack of diversity at the top and feelings of frustration on the lack of progress by rank and file employees. By building an inclusive culture, leaders can ensure under-represented groups stay with organizations and can rise to senior leadership positions. In the IMA D&I Toolkit, we outline five key approaches that we used to measurably increase diversity at IMA, ones which can be replicated by other organizations:

1.Lead from the top. CEOs, board members, D&I committee heads and other senior leaders need to set the tone on D&I and lead by example. They need to be both frank about shortcomings and optimistic about setting and reaching goals, or else staff (and the wider public) will fail to take any commitments seriously. The same goes for transforming individual departments; for the finance function, the tone must be set by the CFO.

2.Create accountability. This means assigning a person to oversee D&I initiatives, one who will be held directly accountable for progress. If D&I is left to a committee or a junior-level executive, accountability will fall by the wayside.

3.Quantify D&I. Its crucial that each organization clarify and measure what goals are involved in making progress on D&I, including employee statistics and whatever other initiatives are launched. This is an area where finance and accounting professionals, under the leadership of the CFO, can play a key role.

4.Communicate initiatives, goals and successes. D&I should be a regular part of all organizational communications, whether is in annual reports, employee communications or marketing materials. This goes beyond optics. The goal is to communicate to stakeholders the importance of D&I and the need for everyone to participate in reaching milestones.

5.Build a diverse leadership pipeline. When it comes to both recruitment and internal promotions, ensuring diverse representation at the top of the corporate ladder should be paramount. Even as overall workforces necessarily become more diverse due to changing demographics, there remains a stubborn racial gap in leadership roles. Overcoming that gap will allow alternate perspectives to be factored into C-Suite decision-making.

Ultimately, organizations can and should use these guidelines to advance along what we call the D&I Continuum, from being merely compliant with legal requirements to fully incorporating D&I into business strategy, practice and mission.

As the leader of a global professional organization, I am especially concerned with adoption of these guidelines by accounting and finance departments and by CFOs in particular, who will play a unique role in transforming our profession to fully embody the principles of D&I. That said, leaders of all types must think about where they are falling short and how they can forge a new future. When it comes to diversity, injustice and lack of opportunity, there will be no excuses for inaction and all leaders must be able to point to concrete policies, goals and benchmarks for change.

Read more from the original source:

Heres How Corporate Leaders Can Make Meaningful Progress On Diversity And Inclusion - Forbes

Report: NBA Making Progress on Plan for 8 Teams Not Included in Orlando Restart – Bleacher Report

Rick Bowmer/Associated Press

The NBA has reportedly "progressed" in discussions about the potential for group workouts and scrimmages involving the eight teams that didn't qualify for the resumption of the 2019-20 season at the Disney World complex in Orlando, Florida.

Rick Bonnell of the Charlotte Observer reported Friday the current proposal under discussion calls for a week of practices at a team's home facility followed by two weeks of workouts and possibly some scrimmages in hub cities, but the plan still needs final approval from the league and Players Association.

The Atlanta Hawks, Charlotte Hornets, Chicago Bulls, Cleveland Cavaliers, Detroit Pistons, Golden State Warriors, Minnesota Timberwolves and New York Knicks didn't qualify for the shortened eight-game finish to the regular season in Orlando.

In turn, those organizations are facing the potential of nearly nine months without competitive basketball with the 2020-21 campaign not scheduled to start until Dec. 1. The current season was halted March 11.

NBPA executive director Michele Roberts raised concerns about whether the league could provide an equally safe environment for those teams as the ones competing for a championship in Orlando.

"I know there are some players, particularly young players, that seem concerned they're not getting enough [opportunities]. I think our teams are incredibly smart and creative and can come up with ways to get their guys engaged, if not now, before the season starts," Robertstold reportersin June. "But I am very concerned and frankly...in terms of play that doesn't have the same guarantees of safety and health that we've provided for the teams in Orlando."

There are also questions about whether veterans would take part in the scrimmages or if it would become more of an informal Summer League setting with mostly young players.

"I probably won't play if it gets approved," an unnamed Cavs player toldChris Fedorof Cleveland.com in early July. "Doubt many vets will."

Hornets head coach James Borrego told Bonnell he believes the eight teams currently sitting on the sidelines will be at a significant competitive disadvantage heading toward next season if no plan is approved.

"We need the door flung open, so we can get after this thing," Borrego said.

A final decision could be announced as early as next week, per Bonnell.

Scrimmages have already started to take place in Orlando with the regular season set to resume Thursday.

Here is the original post:

Report: NBA Making Progress on Plan for 8 Teams Not Included in Orlando Restart - Bleacher Report

Pence to tout incredible progress on a coronavirus vaccine next week in Florida – Tampa Bay Times

Vice President Mike Pence is headed to Miami Monday to promote the Trump administrations progress on efforts to bring a coronavirus vaccine to market.

Pences office announced Thursday that he is scheduled to visit the University of Miami next week to mark the beginning of Phase III trials for a coronavirus vaccine.

The university announced this month that it was looking for volunteers to participate in a study led by the National Institute of Allergy and Infectious Diseases COVID-19 Prevention Network in which 1,000 people will be injected with a potential vaccine by Moderna.

The trial, which is expected to begin next week, is part of a 30,000-person study.

During his visit, Pence, the head of the White Houses coronavirus task force, will participate in a roundtable with university leaders and researchers on the incredible progress of a coronavirus vaccine, Pences office announced in a press release. Pence will speak to the press before returning to Washington.

Pences visit is the latest symptom of the increased attention by the White House to the outbreak in Miami, where positive cases and hospitalizations have surged in recent weeks.

U.S. Surgeon General Jerome Adams visited Miami Thursday and held a press conference at the Camillus House homeless shelter. The previous day, task force response coordinator Deborah Birx warned on a private call that Miami was among 11 cities that should take aggressive steps to slow the spread of the virus.

Miami Herald staff writer Michelle Marchante contributed to this report.

HOW CORONAVIRUS IS SPREADING IN FLORIDA: Find the latest numbers for your county, city or zip code.

LATEST ON CORONAVIRUS: Six things weve learned about the coronavirus since March.

MASK UPDATE: Find out where you have to wear a mask in Tampa Bay

GET THE DAYSTARTER MORNING UPDATE: Sign up to receive the most up-to-date information.

THE CORONAVIRUS SCRAPBOOK: We collected your stories, pictures, songs, recipes, journals and more to show what life has been like during the pandemic.

HAVE A TIP?: Send us confidential news tips

Were working hard to bring you the latest news on the coronavirus in Florida. This effort takes a lot of resources to gather and update. If you havent already subscribed, please consider buying a print or digital subscription.

Link:

Pence to tout incredible progress on a coronavirus vaccine next week in Florida - Tampa Bay Times

Oregon Shows Progress in Tackling Unemployment Numbers – Governing

(TNS) The Oregon Employment Department missed its goal for the third straight week in processing thousands of unpaid benefits claims for self-employed workers who are out of a job during the pandemic.

And the beleaguered departments phone lines suffered fresh outages Tuesday and Wednesday, making it impossible for callers to reach the state to resolve problems with their claims.

Still, there are signs of progress that suggest Oregon is beginning to get a handle on the huge volume of unpaid jobless claims that left tens of thousands of unemployed workers going without income through the heart of the pandemic.

The department has now paid $3.2 billion in benefits since Oregon began its shutdown in March. This time last month there were 70,000 self-employed workers waiting for aid under the new Pandemic Unemployment Assistance program that Congress established in March. Many of those had been waiting for several months for their checks.

The department has whittled that backlog down to 44,000 unprocessed claims, moving more slowly than anticipated. The trajectory for clearing those claims is accelerating, though, and interim director David Gerstenfeld said Wednesday he is increasingly optimistic of working through those 70,000 claims by the Aug. 8 target date he set in June.

Were turning the corner, Gerstenfeld said on his weekly media call Wednesday.

The department has been aided in part by a $240,000,Google-based technology upgrade implemented last Fridayto automate some parts of the claims processing for self-employed workers.

In at least a few cases, the new system appears to have interrupted benefits payments people had been receiving. But Gerstenfeld said its been a huge net positive overall, with automation freeing up his staff to begin working unprocessed claims and accelerate payments.

State lawmakersapproved $500 relief paymentslast week for as many as 70,000 Oregonians who have been waiting the longest for their unemployment benefits. State administrators said at the time it could take several weeks to begin payments, but the Legislatures Democratic leadership indicated Wednesday they have made good progress and hope to launch the program by the end of July.

As Oregon makes advances in other areas, though, the employment department is encountering new problems.

For example, the department has whittled the number of regular, unprocessed jobless claims down from more than 100,000 last spring to just 2,600 now.

Processed claims arent always paid, though. Some need an additional review called adjudication. Gerstenfeld said the typical waiting period for adjudicated claims has grown from 10 weeks to as many as 14 weeks meaning many people with legitimate claims must wait months to see their benefits.

Every Oregon claim is still subject to a one-week period when benefits arent paid, even though Congress funded a waiver of the so-called waiting week in March. The states antiquated computers havent been able to accommodate the change.

The employment department says it will begin attempting to address the waiting week issue in August, but has cautioned it may not be able to implement the waiver by a federal deadline at the end of the year. That would leave hundreds of millions of dollars in federal benefits for Oregonians permanently unpaid, unless the state can secure additional latitude from the feds.

Additionally, this weeks phone outages exacerbated one of the departments thorniest issues.

The department relies primarily on phone calls to resolve questions about unpaid claims and the phones lines have been jammed since March due to the huge volume of new jobless claims and the states byzantine system for processing them.

Also Wednesday, Gerstenfeld disclosed that three more employment department workers have tested positive for the coronavirus. That brings the total number of infections among its staff to 16.

The outbreaks have slowed claims processing, at least modestly, andprompted the closure of the departments Gresham facility earlier this month. Gerstenfeld said that office will reopen Friday, and said the departmentnow requires its staff to wear masksin most situations.

Weve been urging these measures for some time and theyre now mandatory, Gerstenfeld said.

2020 The Oregonian (Portland, Ore.)Distributed byTribune Content Agency, LLC.

See the original post here:

Oregon Shows Progress in Tackling Unemployment Numbers - Governing

Dinwiddie Airport and Industrial Authority opens new executive hangars – Progress Index

Contributed Report

SundayJul26,2020at1:15PM

DINWIDDIE The Dinwiddie County Airport and Industrial Authority, located in North Dinwiddie held a ribbon-cutting ceremony earlier this month for four brand-new executive hangars.

The new executive hangars are located on the front row near the terminal building with access to the taxiway and runway. Each 60 ft. x 60 ft. hangar includes a private bathroom, large electric doors, LED lighting, and night exterior lighting, making them ideal for single and multi-aircraft fleets.

Richard Taylor, chairman of the Dinwiddie Airport and Industrial Authority stated, "These new executive hangars will have a positive impact on economic development in Dinwiddie County, and the region, with a unique offering of corporate hangar space to existing businesses and prospective businesses considering the region."

Dr. Mark Moore is a member of the Board of Supervisors as well as the Dinwiddie Airport and Industrial Authority. Regarding the project he shared, "The Dinwiddie Airport is a strong economic development asset. We believe the addition of these executive hangars will be an attractive option for corporate jets. This investment will allow us to meet the growing needs of the corporate community in Dinwiddie County and our region."

Airport Manager, Jeremy Pultz, stated "This project is just one of many great things that are happening at the Dinwiddie County Airport. We have assembled a new operational team, added new executive hangars and are adopting a new approach to doing business." Pultz added, "We are grateful for the assistance of the Virginia Department of Aviation and Dinwiddie County for helping take the Dinwiddie County Airport to the next level."

For additional information on the Dinwiddie Airport, visit http://www.ptbairport.com.

Read the original:

Dinwiddie Airport and Industrial Authority opens new executive hangars - Progress Index

The Halted Progress of Criminal-Justice Reform – The New Yorker

The cause of criminal-justice reform has been, in recent years, a welcome exception to the extreme polarization that has afflicted so much of our politics. Since 2008, the prison population has dropped in most parts of the country, in both red states and blue. Its gone down sixteen per cent in Louisiana and twenty-two per cent in South Carolina, which is roughly similar to reductions in more liberal places, such as California (twenty-six per cent) and New York (twenty-one per cent). The fight against mass incarceration even engendered a brief moment of bipartisanship in Washington, in 2018, when Congress overwhelmingly passed, and President Trump signed, the First Step Act, which made modest improvements in federal sentencing practices.

But this progress, at least at the federal level, has come to a halt. In the weeks since protests erupted around the nation following the murder of George Floyd, in Minneapolis, on May 25th, the President has returned to the law and order bluster that characterized his 2016 campaign. More to the point, the Justice Department, under Attorney General William Barr, has engaged in precisely the kinds of excesses that the reform movement has endeavored to correct. Most of the protests were peaceful, of course, but there was some violence and destruction of property. These sorts of crimes have traditionally belonged in the bailiwick of state prosecutors, who handle most violent crime in the United States. Yet Barrs prosecutors have stepped in and charged at least seventy people with crimes in connection with the protests. In Mobile, Alabama, a protester allegedly used a bat to break a window of a police cruiser. Such an act is a paradigmatic state crimean assaultbut federal prosecutors contrived to bring a case for civil disorder, drawing on a rarely used federal law. Bringing the case in federal court allows Barr to posture against the protesters and, even more important, to make them eligible for longer prison sentences, as is usually the case in federal prosecutions.

The most egregious example of this kind of federal excess is taking place in New York, where prosecutors in Brooklyn may be on the verge of responding to a crime with an injustice. On May 29th, two well-regarded lawyers, Colinford Mattis and Urooj Rahman, participated in protests in Fort Greene. According to the complaint filed in federal court, just after midnight, Rahman stepped out of a minivan driven by Mattis and flung a Molotov cocktail through a broken window of an unoccupied police car. (In another part of Brooklyn, Samantha Shader, a twenty-seven-year-old woman from upstate New York, was charged in a separate Molotov-cocktail attack on a police van; neither attack caused any injuries.)

The two lawyers are both in their early thirties. Mattis is a graduate of Princeton and of New York Universitys law school, and he worked until recently at a well-known corporate law firm in Manhattan. He is active in community affairs in Brooklyn, and is responsible for the care of several young family members. Rahman, a graduate of Fordham Universitys college and law school, worked at Bronx Legal Services. Neither had a criminal record. (Shader did have a record of various arrests in different parts of the country.) Mattis and Rahman have pleaded not guilty, but the case against them appears strong. According to prosecutors, there is video evidence of Rahman throwing the improvised bomb, and police found the ingredients to make Molotov cocktails in Mattiss van.

In bringing the case against them, though, the Justice Department has engaged in grotesque overreach. If convicted of the charges in the indictment, Mattis and Rahman face a minimum of forty-five years and a maximum of life in prison. (If they were prosecuted in state court, as they should be, they would likely face five years or less.) The case demonstrates the perversity of mandatory-minimum sentences, which remain common in federal court, despite the changes wrought by the First Step Act. The problems with mandatory minimums only begin with the simple fact that they keep people in prison for too many years. They also concentrate power in the hands of prosecutors and remove discretion from judges, who usually have a broader perspective on the appropriate levels of punishment. Moreover, mandatory minimums warp the entire judicial system, by putting unbearable pressure on defendants (and their lawyers) to enter guilty pleas and avoid the risk posed by a trial. (Prosecutors often waive the minimums if defendants offer to plead guilty.)

The case of Mattis and Rahman illustrates this point clearly. Faced with the certainty of decades of prison time if convicted by a jury, what defendant wouldnt try to cut a deal for a lesser sentence? In federal court today, a remarkable ninety-seven per cent of defendants plead guilty rather than go to trial. But a system in which practically no one goes to trial gives government prosecutors far too much power. Judges and juries are supposed to operate as a check on prosecutors, and they cant do that job if nearly every defendant pleads guilty. Too often, prosecutors, like those in the case of Mattis and Rahman, use indictments to extort guilty pleas rather than to achieve justice.

This is, in many respects, a hopeful moment for progress in the criminal-justice system. District attorneys in cities like Philadelphia, Milwaukee, and San Francisco are pulling back from the mindless pursuit of more convictions and longer sentences. Eric Gonzalez, the Brooklyn District Attorney, is also a reformer, which may be a reason that Barrs minions snatched the Molotov-cocktail cases away from him. The Attorney General has expressed nothing but contempt for more civilized approaches to law enforcement. In a speech in February, he attacked the new generation of prosecutors, asserting, These D.A.s think they are helping people, but they end up hurting them. These policies actually lead to greater criminality. This, to put it charitably, is unproven. Reformers have been winning elections around the country not because their constituents want greater criminality but because they recognize that we have incarcerated too many people (and particularly too many people of color) for too long.

As usual, Barr is channelling his boss, who has responded to the George Floyd protests with ugly spasms of race-baiting and bigotry. But, as bad as Trumps invective is on Twitter and elsewhere, Barrs actions are worse, because individuals and communities will be paying the costs for years, or decades, to come.

Read more:

The Halted Progress of Criminal-Justice Reform - The New Yorker